Celularity Inc

Analysis for Ticker: CELU

Celularity Inc researches cell therapies and biobanking, but the math is a total disaster. The company has a deficit of 991,5$ million and a working capital hole of 68,4$ million. They only have 6,2$ million in cash left to stay alive. It is like one child who owes 100$ and only has 1$ in their pocket, but the person they owe money to just told them they owe 115$ because they were late. That is exactly what Helena Global did in 04/2026, delivering a default notice that forces the company to pay 115% of its debt at an 18% interest rate. They are cannibalizing their own revenue-generating business, selling it to a company called NexGel for just 8,3$ million in upfront cash simply to pay off predatory penalties. The board has already stated that without a miracle injection of capital, they will be forced into bankruptcy within twelve months.